Results: 6

    Policy brief: when do vertical (stand-alone) programmes have a place in health systems?

    The terms vertical and integrated are widely used in health service delivery, but each describes a range of phenomena. In practice, the dichotomy between them is not rigid, and the extent of verticality or integration varies between programmes – including (1) a vertically funded, managed, delivered and...

    How can the impact of health technology assessments be enhanced?

    Policy issues• Health technology assessment (HTA) is an important tool for informing effective regulation of the diffusion and use of health technologies.• The key policy issues surrounding the use of HTA fall into three areas: (a) the bodies, decision-makers and other stakeholders involved, (b) the ...

    How can European health systems support investment in and the implementation of population health strategies?

    Key messagesPolicy issue and associated policy challenges• Population health is influenced by a variety of factors, many of whichrequire action outside the health system.• The health and socioeconomic costs of the key contributors to poor healthin Europe are substantial. Many of these health problems...

    Policy brief: how can optimal skill mix be effectively implemented and why?

    Skill-mix initiatives focus on changing professional roles - directly and indirectly.They change roles directly through extension of roles or skills, delegation, andthe introduction of a new type of worker; they change them indirectly throughmodifications of the interface between services - that is, wher...

    Policy brief: How can the settings used to provide care to older people be balanced?

    The optimal balance between institutional, home-based and community care for older adults requires an effective mix of organizational, funding and delivery mechanisms for target populations. This spans health and social care, and the coordination of care must respect older people’s care preferences and...

    Should patient decision aids (PtDAs) be introduced in the health care system?

    “Grey zone” treatments are those that rely upon the patient’s judgement of associated benefits versus harms. When clinicians judge patients are eligible for “grey zone” treatments, their acceptance should be consistent with informed patients’ values. The question is how can one obtain informe...